Details of the Drug Reposition

General Information of This Drug (ID: DMK8PTH)

Drug Name
PRM-151   DMK8PTH

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelofibrosis DISIMP21 2A20.2 Phase 2 [1]
Thrombocythemia DISL38J3 3B63 Phase 2 [2]
Macular degeneration DISLKKHD 9B78.3 Phase 2 [3]
Idiopathic pulmonary fibrosis DISZGA69 CB03.4 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News Perspect. 2010 Jun;23(5):305-15.